BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 19698015)

  • 1. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Mitrano JA; Spooner LM; Belliveau P
    Pharmacotherapy; 2009 Sep; 29(9):1103-9. PubMed ID: 19698015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of infections caused by resistant Staphylococcus aureus.
    Anstead GM; Quinones-Nazario G; Lewis JS
    Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T; Alan T
    Hawaii Med J; 2006 Oct; 65(10):290-3. PubMed ID: 17194061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.
    Drew RH
    Pharmacotherapy; 2007 Feb; 27(2):227-49. PubMed ID: 17253914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Cadena J; Javeri H
    Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease.
    Buitrago MI; Crompton JA; Bertolami S; North DS; Nathan RA
    Pharmacotherapy; 2009 Mar; 29(3):347-51. PubMed ID: 19249952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
    Sabol KE; Echevarria KL; Lewis JS
    Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K; Perez A; Ramage G; Gemmell CG; Lang S
    Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature.
    Ruhe JJ; Monson T; Bradsher RW; Menon A
    Clin Infect Dis; 2005 May; 40(10):1429-34. PubMed ID: 15844065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
    Tverdek FP; Crank CW; Segreti J
    Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
    Le J; Lieberman JM
    Pharmacotherapy; 2006 Dec; 26(12):1758-70. PubMed ID: 17125437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic selection for MRSA: case presentations and review of the literature.
    Hanson MR; Chung CL
    J Drugs Dermatol; 2009 Mar; 8(3):281-6. PubMed ID: 19271378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin-resistant Staphylococcus aureus infections.
    Bartlett JG
    Top HIV Med; 2008 Dec; 16(5):151-5. PubMed ID: 19106430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.